Biotechnology Value Fund L P - Jul 1, 2025 SCHEDULE 13G Report for NEKTAR THERAPEUTICS Common Stock, $0.0001 par value

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
NEKTAR THERAPEUTICS Common Stock, $0.0001 par value
Shares outstanding
17.3M shares
Disclosed Ownership
1.28M shares
Ownership
7.4%
Form type
SCHEDULE 13G
Date filed
7/9/2025, 04:39 PM
Date of event
Jul 1, 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 3.8% 662K 0 662K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 3.8% 662K 0 662K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 3% 518K 0 518K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 3% 518K 0 518K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.4% 71.4K 0 71.4K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.4% 71.4K 0 71.4K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 6.8% 1.18M 0 1.18M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 7.4% 1.28M 0 1.28M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 7.4% 1.28M 0 1.28M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 7.4% 1.28M 0 1.28M /s/ Mark N. Lampert Mark N. Lampert